All In Biotech

Drug Trial Radar · NCT05701917

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

DEFIANCE - ClotTriever® Thrombectomy System vs. Anticoagulation Alone for Treatment of Deep Vein Thrombosis

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

300

Planned (sponsor's estimate)

Start

Jan 6, 2023

Primary completion

Jan 31, 2028

Study completion Jul 31, 2028

Sponsor

Lead sponsor
Inari MedicalIndustry
Sponsor type
Industry
First posted
Jan 27, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conservative Medical Management Arm) in the treatment of subjects with symptomatic unilateral iliofemoral DVT. The study will collect data on demographics, comorbidities, details from the DVT diagnosis and treatment, and clinical outcomes through the 6-month follow up visit.

Conditions

  • Venous Thromboembolism
  • Deep Venous Thrombosis
  • Post-Thrombotic Syndrome

Interventions

  • ClotTriever SystemDevice

    Mechanical thrombectomy

  • Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc.Drug

    Anticoagulants are a group of medications that decrease your blood's ability to clot.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Composite clinical endpoint constructed as a win ratio, a hierarchy of the following:Time frame: 180 Days (+-14 Days)

Locations

64 sites in 6 countries. Site status is shown where the registry gives one.

  • Honor Health

    Scottsdale, Arizona · Recruiting

  • Pima Heart and Vascular

    Tucson, Arizona · Recruiting

  • UCI Medical Center

    Orange, California · Recruiting

  • Vascular and Interventional Specialists of Orange County

    Orange, California · Recruiting

  • Huntington Health

    Pasadena, California · Recruiting

  • University Of Colorado

    Denver, Colorado · Recruiting

  • Yale University

    New Haven, Connecticut · Recruiting

  • MedStar Health Research Institution

    Washington D.C., District of Columbia · Recruiting

  • Manatee Memorial Hospital

    Bradenton, Florida · Terminated

  • Baptist Health Research Institute

    Jacksonville, Florida · Recruiting

  • Lakeland Vascular Institute

    Lakeland, Florida · Terminated

  • HCA Florida Largo Hospital

    Largo, Florida · Terminated

  • Sarasota Memorial Hospital

    Sarasota, Florida · Recruiting

  • BayCare Health System

    Tampa, Florida · Recruiting

  • Memorial Health University Medical Center

    Savannah, Georgia · Terminated

  • Community Healthcare System

    Munster, Indiana · Terminated

  • St. Elizabeth Edgewood

    Edgewood, Kentucky · Terminated

  • University of Maryland

    Baltimore, Maryland · Recruiting

  • McLaren Healthcare

    Bay City, Michigan · Recruiting

  • Henry Ford Health

    Detroit, Michigan · Recruiting

  • MyMichigan Medical Center

    Midland, Michigan · Recruiting

  • University of Missouri

    Columbia, Missouri · Recruiting

  • Saint Luke's Hospital of Kansas City

    Kansas City, Missouri · Terminated

  • St. Louis University

    St Louis, Missouri · Recruiting

  • University Medical Center of Southern Nevada

    Las Vegas, Nevada · Recruiting

  • Cooper University Hospital

    Camden, New Jersey · Recruiting

  • Holy Name Medical Center

    Teaneck, New Jersey · Terminated

  • Northwell Health

    Bay Shore, New York · Recruiting

  • NYP-Brooklyn Methodist

    Brooklyn, New York · Recruiting

  • SUNY, The University at Buffalo

    Buffalo, New York · Terminated

  • NYU Langone Medical Center

    New York, New York · Recruiting

  • Columbia University Irving Medical Center

    New York, New York · Recruiting

  • Mission Health

    Asheville, North Carolina · Terminated

  • Mercy Health - The Heart Institute

    Cincinnati, Ohio · Terminated

  • Cleveland Clinic

    Cleveland, Ohio · Recruiting

  • Saint Francis Hospital

    Tulsa, Oklahoma · Recruiting

  • Allegheny St. Vincent Hospital

    Erie, Pennsylvania · Recruiting

  • Thomas Jefferson University

    Philadelphia, Pennsylvania · Recruiting

  • Allegheny General Health Research Network

    Pittsburgh, Pennsylvania · Recruiting

  • Rhode Island Hospital

    Providence, Rhode Island · Recruiting

Showing 40 of 64 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.